Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$242.49 - $301.46 $127,307 - $158,266
525 Added 9.52%
6,040 $1.48 Million
Q2 2022

Aug 09, 2022

BUY
$224.73 - $338.64 $269,226 - $405,690
1,198 Added 27.75%
5,515 $1.37 Million
Q1 2022

May 06, 2022

BUY
$277.25 - $366.29 $12,199 - $16,116
44 Added 1.03%
4,317 $1.43 Million
Q4 2021

Feb 08, 2022

BUY
$300.63 - $371.35 $71,249 - $88,009
237 Added 5.87%
4,273 $1.54 Million
Q3 2021

Nov 09, 2021

BUY
$310.19 - $376.2 $39,083 - $47,401
126 Added 3.22%
4,036 $1.31 Million
Q2 2021

Aug 16, 2021

BUY
$262.71 - $351.17 $11,296 - $15,100
43 Added 1.11%
3,910 $1.22 Million
Q1 2021

May 14, 2021

SELL
$285.92 - $355.13 $22,587 - $28,055
-79 Reduced 2.0%
3,867 $1.23 Million
Q3 2020

Nov 05, 2020

BUY
$255.22 - $317.0 $19,141 - $23,775
75 Added 1.94%
3,946 $1.09 Million
Q2 2020

Jul 28, 2020

BUY
$141.4 - $257.09 $9,049 - $16,453
64 Added 1.68%
3,871 $935,000
Q1 2020

Apr 30, 2020

SELL
$130.51 - $196.01 $38,761 - $58,214
-297 Reduced 7.24%
3,807 $553,000
Q4 2019

Feb 14, 2020

BUY
$159.31 - $223.54 $9,717 - $13,635
61 Added 1.51%
4,104 $700,000
Q3 2019

Oct 30, 2019

SELL
$175.89 - $279.23 $8,794 - $13,961
-50 Reduced 1.22%
4,043 $719,000
Q2 2019

Aug 05, 2019

BUY
$250.96 - $284.94 $21,331 - $24,219
85 Added 2.12%
4,093 $1.07 Million
Q1 2019

May 06, 2019

BUY
$276.39 - $362.25 $43,116 - $56,511
156 Added 4.05%
4,008 $1.15 Million
Q4 2018

Feb 12, 2019

SELL
$281.08 - $444.25 $1,124 - $1,777
-4 Reduced 0.1%
3,852 $1.25 Million
Q3 2018

Nov 02, 2018

BUY
$354.53 - $449.75 $53,179 - $67,462
150 Added 4.05%
3,856 $1.73 Million
Q2 2018

Aug 09, 2018

BUY
$278.07 - $446.21 $622,320 - $998,617
2,238 Added 152.45%
3,706 $1.52 Million
Q3 2017

Nov 06, 2017

BUY
$145.39 - $168.6 $213,432 - $247,504
1,468
1,468 $248,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.